Showing results (161-170 of 206) with videos related to
Sort By:
Pageof 21
Genetic Epidemiology|July 22, 1998
Modelling the major histocompatibility complex susceptibility to RA using the MASC methodE Génin, M C Babron, M F McDermott, et al.Bioengineering (Basel, Switzerland)|July 25, 2022
Microcarrier-Based Culture of Human Pluripotent Stem-Cell-Derived Retinal Pigmented EpitheliumMohamed A Faynus, Jeffrey K Bailey, Britney O Pennington, et al.Arthritis Care & Research|March 2, 2010
Development and validation of a case ascertainment tool for ankylosing spondylitisMichael H Weisman, Lan Chen, Daniel O Clegg, et al.Annals of the Rheumatic Diseases|October 31, 2007
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitisJ C Davis, D M van der Heijde, J Braun, et al.Journal of Tropical Pediatrics|March 24, 2000
Bacterial, viral and parasitic aetiology of paediatric diarrhoea in the highlands of Papua New GuineaP Howard, N D Alexander, A Atkinson, et al.The Journal of Rheumatology|May 20, 2008
2007 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN)Robert A Colbert, Atul A Deodhar, Muhammad Asim Khan, et al.Developmental Biology|December 8, 2004
Integrin alpha4beta1 function is required for cell survival in developing retinaSergiu T Leu, Susan A L Jacques, Kevin L Wingerd, et al.Nature Biotechnology|May 16, 2017
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cellsGermán G Gornalusse, Roli K Hirata, Sarah E Funk, et al.Rheumatology International|November 1, 2021
Tumor necrosis factor inhibitor (TNFi) persistence and reasons for discontinuation in a predominantly male cohort with axial spondyloarthritisDelamo I Bekele, Elizabeth Cheng, Andreas Reimold, et al.Arthritis and Rheumatism|March 4, 1998
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trialM L Barnett, J M Kremer, E W St Clair, et al.Pageof 21